Roger that. Thanks
- Forums
- ASX - By Stock
- PAR
- Ann: PAR Selects Advanced Clinical as CRO for Phase 3
PAR
paradigm biopharmaceuticals limited..
Add to My Watchlist
4.65%
!
41.0¢

Ann: PAR Selects Advanced Clinical as CRO for Phase 3, page-9
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
41.0¢ |
Change
-0.020(4.65%) |
Mkt cap ! $162.9M |
Open | High | Low | Value | Volume |
41.5¢ | 42.5¢ | 40.5¢ | $103.5K | 250.8K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 1700 | 41.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
41.5¢ | 9236 | 5 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 1700 | 0.410 |
6 | 47954 | 0.405 |
9 | 124371 | 0.400 |
8 | 85743 | 0.395 |
9 | 60486 | 0.390 |
Price($) | Vol. | No. |
---|---|---|
0.415 | 9729 | 6 |
0.420 | 9962 | 4 |
0.425 | 32657 | 5 |
0.430 | 15050 | 3 |
0.435 | 11447 | 2 |
Last trade - 11.57am 28/07/2025 (20 minute delay) ? |
Featured News
PAR (ASX) Chart |
The Watchlist
P.HOTC
HotCopper
Frazer Bourchier, Director, President and CEO
Frazer Bourchier
Director, President and CEO
SPONSORED BY The Market Online